Beryl Drugs Ltd Faces Intense Selling Pressure Amid Significant Price Declines

Beryl Drugs Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past six days, resulting in a total loss of 11.78% during this period. Today, Beryl Drugs' stock price fell by 3.93%, contrasting sharply with the Sensex, which posted a modest gain of 0.11%.
Over the past week, Beryl Drugs has underperformed the Sensex, with a decline of 11.71% compared to the index's increase of 0.33%. The stock's performance over the last month also reflects a downward trend, with a loss of 2.69% against the Sensex's gain of 3.83%. More strikingly, the stock has plummeted 42.85% over the past three months, while the Sensex has risen by 4.71%.

Currently, Beryl Drugs is trading just 0.1% away from its 52-week low of Rs 20.27 and has underperformed its sector by 4.55%. The stock is also trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a sustained bearish trend. These factors collectively contribute to the ongoing selling pressure observed in Beryl Drugs Ltd.